The unlikely coalition of a military government that overthrew a democratically-elected government of Thailand in 2006 and non-governmental organizations concerned about access for poorer people to essential drugs has been condemned as "Baptists and bootleggers" by Philip Stevens of the International Policy Network, a UK-headquartered global development think-tank.
Mr Stevens was writing in the Medical Progress Today, an Internet-based magazine produced by the US think-tank the Manhattan Institute. In his article, the IPN's health program director claimed that the "consumerist" interests publicly-supported by NGOs are in fact in contrast with the self-serving attitude of the Thai government. In particular, the Government Pharmaceutical Organization, a state-owned drugmaker, was accused of exploiting the issue of access to drugs for poorer people in Thailand, to justify the seizure of intellectual property belonging to foreign drugmakers (Marketletters passim).
Mr Stevens argued that the GPO is motivated by more monetary considerations than altruism. He said: "behind all the talk of increasing access to medicines, the Thai government's true intention is to establish itself as a dominant regional manufacturer of generic drugs." He added that the track record of the GPO in terms of corruption and mismanagement were not hopeful for the future needs of Thai HIV/AIDS patients. In 2002, the Auditor General reported that $13.0 million had been stolen by the GPO from the government over the previous four years. Drugs were also sold to patients at mark ups of "up to 1,000%."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze